Biohaven Ltd. Shares Outstanding (Cover Page)
Biohaven Ltd. (BHVN) had Shares Outstanding (Cover Page) of 151.04 million shares as of 2026-08-06, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-06: Entity Common Stock, Shares Outstanding 151.04M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 150.56M shares.
- 2026-02-26: Entity Common Stock, Shares Outstanding 150.42M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 105.86M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 151.04M shares 10-Q · filed 2026-08-10 |
| 2026-04-30 | 150.56M shares 10-Q · filed 2026-05-04 |
| 2026-02-26 | 150.42M shares 10-K · filed 2026-03-02 |
| 2025-11-06 | 105.86M shares 10-Q · filed 2025-11-10 |
| 2025-08-08 | 105.79M shares 10-Q · filed 2025-08-11 |
| 2025-05-09 | 102.11M shares 10-Q · filed 2025-05-12 |
| 2025-02-28 | 102.05M shares 10-K · filed 2025-03-03 |
| 2024-11-08 | 101.12M shares 10-Q · filed 2024-11-12 |
| 2024-08-06 | 94.54M shares 10-Q · filed 2024-08-09 |
| 2024-05-06 | 88.29M shares 10-Q · filed 2024-05-09 |
| 2024-02-26 | 81.58M shares 10-K · filed 2024-02-29 |
| 2023-11-10 | 80.23M shares 10-Q · filed 2023-11-14 |
| 2023-07-27 | 68.32M shares 10-Q · filed 2023-07-31 |
| 2023-05-09 | 68.22M shares 10-Q · filed 2023-05-12 |
| 2023-03-20 | 68.21M shares 10-K · filed 2023-03-23 |
| 2022-11-07 | 68.16M shares 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |